Related Experiment Video
Updated: Jun 29, 2026

A Protocol to Acquire the Degenerative Tenocyte from Humans
Published on: June 9, 2018
[Diagnosis and management of tenosynovial giant cell tumor]
Canelle Bakota-Morrison1, Roland Strasser1, Igor Letovanec2,3
1Service d'orthopédie et traumatologie, Département de l'appareil locomoteur, Centre des sarcomes, Centre hospitalier universitaire vaudois, 1011 Lausanne.
Abstract:
Tenosynovial giant cell tumor is a benign condition that originates from synovial cells within joints, tendon sheaths, or bursae and may present either in localized (benign) or diffuse (locally aggressive) forms. Currently, the primary treatment approach is surgical, yielding satisfactory results with low recurrence rates in the localized forms, whereas the diffuse type displays high recurrence rates. In parallel, clinical trials are underway to explore pharmaceutical treatment options for the advanced diffuse type. This article aims at consolidating current knowledge about diagnosis and management of this rare tumor, additionally proposing a brief overview of novel therapeutic approaches.
More Related Videos
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Pericarditis III: Medical Management
Aneurysm III: Interprofessional Care

